|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.420 USD | +1.57% |
|
+0.24% | -27.60% |
| 07/07 | RBC Capital Trims CorMedix Price Target to $13 From $14, Maintains Outperform Rating | MT |
| 03/07 | CorMedix Names Elizabeth Hurlburt as Chief Operating, Commercial Officer | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 15 | +78.15% | 5 | ||||||
| 134.04 | +5.13% | 26 | ||||||
| 145.86 | +7.01% | 14 | ||||||
| 83.9 | +7.83% | 10 | ||||||
| 2,240.91 | -15.58% | 11 | ||||||
| 1,34,909.09 | +69.91% | 11 | ||||||
| - | - | 43.06 | -25.64% | 1 | ||||
| 1,27,555.56 | +80.16% | 18 | ||||||
| 63.5 | +32.18% | 6 | ||||||
| - | - | - | - | - | ||||
| 4,833.33 | +16.05% | 6 | ||||||
| 49.25 | +16.38% | 4 | ||||||
| 3.8 | +46.15% | 3 | ||||||
| Average | 22,506.44 | +26.48% | 10 | ||||||
| Weighted average by Cap. | 2,616.34 | +6.53% | 23 |
- Stock Market
- Stocks
- CRMD Stock
- Sector CorMedix Inc.
- Sector consensus
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition